美麗田園醫療健康(02373.HK):CPE擬出售所持有的約5133萬股公司股份
格隆匯6月25日丨美麗田園醫療健康(02373.HK)公告,公司已接獲公司主要股東中信產業投資基金管理有限公司(CPE,其股權系通過Beijing Xinyu Meiye HoldingsLimited持有)通知,截止至2025年6月25日,CPE已達成一系列相關協議或完成相關交易,擬出售其所持有的約5133萬股公司股份(相當於截至本公告日期,公司已發行股份總數(不包括任何庫存股)約21.77%),在完成該系列交易後,CPE將不再作爲公司主要股東。
公司進一步獲CPE告知,該系列交易的投資者包括外資長線醫療健康領域基金、科技創新戰略投資基金、國際領先的長線基金、國際優質對衝基金等(統稱新投資者)。公司相信這顯示了新投資者對中國美麗健康產業黃金髮展期的堅定看好,反映了對集團行業領導地位與發展潛力的認可。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.